BRAINSTORM CELL THERAPEUTICS INC. Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) reported Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture of $25.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2021-02-04.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation · last filed 2021-02-04
- BRAINSTORM CELL THERAPEUTICS INC. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- BRAINSTORM CELL THERAPEUTICS INC. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2019-09-30 was $0.00.
- BRAINSTORM CELL THERAPEUTICS INC. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2019-06-30 was $0.00.
- BRAINSTORM CELL THERAPEUTICS INC. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2019-03-31 was $25.00K.
- BRAINSTORM CELL THERAPEUTICS INC. shares granted, value, share-based payment arrangement, after forfeiture for fiscal 2019 was $25.00K, a 75.49% decline from fiscal 2018.
- BRAINSTORM CELL THERAPEUTICS INC. shares granted, value, share-based payment arrangement, after forfeiture for fiscal 2018 was $102.00K, a 64.52% increase from fiscal 2017.
- BRAINSTORM CELL THERAPEUTICS INC. shares granted, value, share-based payment arrangement, after forfeiture for fiscal 2017 was $62.00K, a 48.76% decline from fiscal 2016.
- BRAINSTORM CELL THERAPEUTICS INC. shares granted, value, share-based payment arrangement, after forfeiture for fiscal 2016 was $121.00K, a 12.04% increase from fiscal 2015.
| Period end | Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture 3 month | Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture 6 month | Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture 9 month | Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-04 | $0.00 derived: sum of 2 quarters · filed 2021-02-04 | $0.00 derived: sum of 3 quarters · filed 2021-02-04 | $25.00K 10-K · filed 2021-02-04 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $0.00 derived: sum of 2 quarters · filed 2019-11-14 | $25.00K 10-Q · filed 2019-11-14 | $127.00K derived: sum of 4 quarters · filed 2020-10-15 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $25.00K 10-Q · filed 2019-08-13 | $127.00K derived: sum of 3 quarters · filed 2020-10-15 | $127.00K derived: sum of 4 quarters · filed 2020-10-15 |
| 2019-03-31 | $25.00K 10-Q · filed 2020-10-15 | $127.00K derived: sum of 2 quarters · filed 2020-10-15 | $127.00K derived: sum of 3 quarters · filed 2020-10-15 | $127.00K derived: sum of 4 quarters · filed 2020-10-15 |
| 2018-12-31 | $102.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $102.00K derived: sum of 2 quarters · filed 2020-02-18 | $102.00K derived: sum of 3 quarters · filed 2020-02-18 | $102.00K 10-K · filed 2020-02-18 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-29 | $0.00 derived: sum of 2 quarters · filed 2018-10-29 | $0.00 10-Q · filed 2018-10-29 | $44.00K derived: sum of 4 quarters · filed 2019-04-01 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-23 | $0.00 10-Q · filed 2018-07-23 | $44.00K derived: sum of 3 quarters · filed 2019-04-01 | |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-14 | $44.00K derived: sum of 2 quarters · filed 2019-04-01 | ||
| 2017-12-31 | $44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $62.00K 10-K · filed 2019-04-01 | ||
| 2017-09-30 | $18.00K 10-Q · filed 2017-10-17 | |||
| 2017-03-31 | $0.00 10-Q · filed 2017-05-15 | $0.00 derived: sum of 2 quarters · filed 2018-03-08 | $90.00K derived: sum of 3 quarters · filed 2018-03-08 | $90.00K derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $90.00K derived: sum of 2 quarters · filed 2018-03-08 | $90.00K derived: sum of 3 quarters · filed 2018-03-08 | $121.00K 10-K · filed 2018-03-08 |
| 2016-09-30 | $90.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $90.00K derived: sum of 2 quarters · filed 2016-11-14 | $121.00K 10-Q · filed 2016-11-14 | $121.00K derived: sum of 4 quarters · filed 2017-03-29 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $31.00K 10-Q · filed 2016-08-11 | $31.00K derived: sum of 3 quarters · filed 2017-03-29 | $31.00K derived: sum of 4 quarters · filed 2017-03-29 |
| 2016-03-31 | $31.00K 10-Q · filed 2016-05-10 | $31.00K derived: sum of 2 quarters · filed 2017-03-29 | $31.00K derived: sum of 3 quarters · filed 2017-03-29 | $139.00K derived: sum of 4 quarters · filed 2017-03-29 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | $0.00 derived: sum of 2 quarters · filed 2017-03-29 | $108.00K derived: sum of 3 quarters · filed 2017-03-29 | $108.00K 10-K · filed 2017-03-29 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | $108.00K derived: sum of 2 quarters · filed 2015-11-16 | $108.00K 10-Q · filed 2015-11-16 | $120.00K derived: sum of 4 quarters · filed 2016-03-09 |
| 2015-06-30 | $108.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $108.00K 10-Q · filed 2015-08-13 | $120.00K derived: sum of 3 quarters · filed 2016-03-09 | $196.00K derived: sum of 4 quarters · filed 2016-03-09 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-14 | $12.00K derived: sum of 2 quarters · filed 2016-03-09 | $88.00K derived: sum of 3 quarters · filed 2016-03-09 | $88.00K derived: sum of 4 quarters · filed 2016-03-09 |
| 2014-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | $88.00K derived: sum of 2 quarters · filed 2016-03-09 | $88.00K derived: sum of 3 quarters · filed 2016-03-09 | $198.00K 10-K · filed 2016-03-09 |
| 2014-09-30 | $76.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $76.00K derived: sum of 2 quarters · filed 2014-11-13 | $186.00K 10-Q · filed 2014-11-13 | $200.00K derived: sum of 4 quarters · filed 2015-08-13 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $110.00K 10-Q · filed 2014-08-12 | $124.00K derived: sum of 3 quarters · filed 2015-08-13 | $135.00K derived: sum of 4 quarters · filed 2015-08-13 |
| 2014-03-31 | $110.00K 10-Q · filed 2014-05-13 | $124.00K derived: sum of 2 quarters · filed 2015-08-13 | $135.00K derived: sum of 3 quarters · filed 2015-08-13 | $209.00K derived: sum of 4 quarters · filed 2015-08-13 |
| 2013-12-31 | $14.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2015-08-13 | $25.00K derived: sum of 2 quarters · filed 2015-08-13 | $99.00K derived: sum of 3 quarters · filed 2015-08-13 | $197.00K 10-Q · filed 2015-08-13 |
| 2013-09-30 | $11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $85.00K derived: sum of 2 quarters · filed 2013-11-14 | $183.00K 10-Q · filed 2013-11-14 | $170.00K derived: sum of 4 quarters · filed 2014-05-13 |
| 2013-06-30 | $74.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $172.00K 10-Q · filed 2013-08-14 | $159.00K derived: sum of 3 quarters · filed 2014-05-13 | $359.00K derived: sum of 4 quarters · filed 2014-05-13 |
| 2013-03-31 | $98.00K 10-Q · filed 2013-05-09 | $85.00K derived: sum of 2 quarters · filed 2014-05-13 | $285.00K derived: sum of 3 quarters · filed 2014-05-13 | $289.00K derived: sum of 4 quarters · filed 2014-05-13 |
| 2012-12-31 | -$13.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2014-05-13 | $187.00K derived: sum of 2 quarters · filed 2014-05-13 | $191.00K derived: sum of 3 quarters · filed 2014-05-13 | $195.00K 10-Q · filed 2014-05-13 |
| 2012-09-30 | $200.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-13 | $204.00K derived: sum of 2 quarters · filed 2012-11-13 | $208.00K 10-Q · filed 2012-11-13 | $411.00K derived: sum of 4 quarters · filed 2014-05-13 |
| 2012-06-30 | $4.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-29 | $8.00K 10-Q/A · filed 2012-08-29 | $211.00K derived: sum of 3 quarters · filed 2014-05-13 | $235.00K derived: sum of 4 quarters · filed 2014-05-13 |
| 2012-03-31 | $4.00K 10-Q · filed 2012-05-11 | $207.00K derived: sum of 2 quarters · filed 2014-05-13 | $231.00K derived: sum of 3 quarters · filed 2014-05-13 | $473.00K derived: sum of 4 quarters · filed 2014-05-13 |
| 2011-12-31 | $203.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2014-05-13 | $227.00K derived: sum of 2 quarters · filed 2014-05-13 | $469.00K derived: sum of 3 quarters · filed 2014-05-13 | $449.00K 10-Q · filed 2014-05-13 |
| 2011-09-30 | $24.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | $266.00K derived: sum of 2 quarters · filed 2011-11-14 | $246.00K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $242.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2011-09-07 | $222.00K 10-Q/A · filed 2011-09-07 | ||
| 2011-03-31 | -$20.00K 10-Q · filed 2012-05-11 | |||
| 2010-12-31 | $96.00K 10-Q · filed 2014-05-13 | |||
| 2009-12-31 | $775.00K 10-Q · filed 2014-05-13 | |||
| 2008-12-31 | $33.00K 10-Q · filed 2014-05-13 | |||
| 2007-12-31 | $1.45M 10-Q · filed 2014-05-13 | |||
| 2006-12-31 | $453.00K 10-Q · filed 2014-05-13 | |||
| 2006-03-31 | $662.00K 10-Q · filed 2014-05-13 | |||
| 2005-03-31 | $17.51M 10-Q · filed 2014-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |